EP3654987 - USE OF AMINOALKYLBENZOTHIAZEPINE DERIVATIVES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 07.07.2023 Database last updated on 26.06.2024 | |
Former | The patent has been granted Status updated on 29.07.2022 | ||
Former | Grant of patent is intended Status updated on 24.03.2022 | ||
Former | Request for examination was made Status updated on 24.04.2020 | ||
Former | The international publication has been made Status updated on 26.01.2019 | Most recent event Tooltip | 24.05.2024 | Lapse of the patent in a contracting state New state(s): IT | published on 26.06.2024 [2024/26] | Applicant(s) | For all designated states HK inno.N Corporation 6F, 7F and 8F, 100, Eulji-ro Jung-gu Seoul 04551 / KR | [2020/38] |
Former [2020/22] | For all designated states CJ Healthcare Corporation A-6F 7F, 8F 100 Eulji-ro Jung-gu Seoul 04551 / KR | Inventor(s) | 01 /
JUN, Hyungjin 302-1702 12 Jukhyeon-ro Giheung-gu Yongin-si Gyeonggi-do 16902 / KR | 02 /
KI, So Young 301 70-4 Daehak 1-ro 8beon-gil Yeongtong-gu Suwon-si Gyeonggi-do 16226 / KR | 03 /
LEE, Keunho 101-1203 109 Yangjae-daero 2-gil Seocho-gu Seoul 06767 / KR | 04 /
JUNG, Jin Woo 401 62 Cheonho-daero 123-gil Gwangjin-gu Seoul 04923 / KR | 05 /
KIM, Dong Hyun 206-802 19 Taejang-ro 71beon-gil Yeongtong-gu Suwon-si Gyeonggi-do 16688 / KR | 06 /
PARK, Chi Hye 323-705 17 Junganggongwon-ro Bundang-gu Seongnam-si Gyeonggi-do 13588 / KR | 07 /
BAK, Hyoung Rok A-1001 13 Jeongui-ro 7-gil Songpa-gu Seoul 05835 / KR | 08 /
RYU, Shin-Young 106-504 180 Deokso-ro Wabu-eup Namyangju-si Gyeonggi-do 12273 / KR | 09 /
LEE, Ju Hyun 1008-1302 45 Gwanggyohosugongwon-ro Yeongtong-gu Suwon-si Gyeonggi-do 16516 / KR | 10 /
LEE, Ho-Youl 2-201 285 Saemal-gil Opo-eup Gwangju-si Gyeonggi-do 12771 / KR | 11 /
JUNG, Won-Hyuk 202-1101 90 Guseong-ro Giheung-gu Yongin-si Gyeonggi-do 16919 / KR | 12 /
KO, Dong Hyun 2F 5-5 Hyangchon 1-gil Gwacheon-si Gyeonggi-do 13834 / KR | 13 /
KIM, Seungin 204 34 Sinwon-ro 136beon-gil Yeongtong-gu Suwon-si Gyeonggi-do 16679 / KR | 14 /
BYUN, Joonseok 401 112-2 Sinwon-ro Yeongtong-gu Suwon-si Gyeonggi-do 16679 / KR | 15 /
YOO, Jae Ho 1466-1801 122 Dongtandaerosibeom-gil Hwaseong-si Gyeonggi-do 18476 / KR | 16 /
JI, Seunghee 68 Achasan-ro 55-gil Gwangjin-gu Seoul 05041 / KR | [2020/22] | Representative(s) | Ruscoe, Peter James Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [2020/22] | Application number, filing date | 18835549.9 | 20.07.2018 | [2020/22] | WO2018KR08211 | Priority number, date | KR20170092852 | 21.07.2017 Original published format: KR 20170092852 | [2020/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019017724 | Date: | 24.01.2019 | Language: | EN | [2019/04] | Type: | A1 Application with search report | No.: | EP3654987 | Date: | 27.05.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 24.01.2019 takes the place of the publication of the European patent application. | [2020/22] | Type: | B1 Patent specification | No.: | EP3654987 | Date: | 31.08.2022 | Language: | EN | [2022/35] | Search report(s) | International search report - published on: | KR | 24.01.2019 | (Supplementary) European search report - dispatched on: | EP | 26.03.2021 | Classification | IPC: | A61K31/554, A61P1/16, A61P3/06 | [2021/17] | CPC: |
A61K31/554 (EP,KR,US);
A61P1/16 (EP);
A61P3/06 (EP)
|
Former IPC [2020/22] | A61K31/554 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/22] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VERWENDUNG VON AMINOALKYLBENZOTHIAZEPINDERIVATEN | [2020/22] | English: | USE OF AMINOALKYLBENZOTHIAZEPINE DERIVATIVES | [2020/22] | French: | UTILISATION DE DÉRIVÉS AMINOALKYLBENZOTHIAZÉPINE | [2020/22] | Entry into regional phase | 05.12.2019 | National basic fee paid | 05.12.2019 | Search fee paid | 05.12.2019 | Designation fee(s) paid | 05.12.2019 | Examination fee paid | Examination procedure | 05.12.2019 | Examination requested [2020/22] | 20.10.2021 | Amendment by applicant (claims and/or description) | 25.03.2022 | Communication of intention to grant the patent | 21.07.2022 | Fee for grant paid | 21.07.2022 | Fee for publishing/printing paid | 21.07.2022 | Receipt of the translation of the claim(s) | Opposition(s) | 01.06.2023 | No opposition filed within time limit [2023/32] | Fees paid | Renewal fee | 29.07.2020 | Renewal fee patent year 03 | 28.07.2021 | Renewal fee patent year 04 | 22.07.2022 | Renewal fee patent year 05 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AL | 31.08.2022 | AT | 31.08.2022 | CZ | 31.08.2022 | DK | 31.08.2022 | EE | 31.08.2022 | ES | 31.08.2022 | FI | 31.08.2022 | HR | 31.08.2022 | IT | 31.08.2022 | LT | 31.08.2022 | LV | 31.08.2022 | MC | 31.08.2022 | NL | 31.08.2022 | PL | 31.08.2022 | RO | 31.08.2022 | RS | 31.08.2022 | SE | 31.08.2022 | SI | 31.08.2022 | SK | 31.08.2022 | SM | 31.08.2022 | NO | 30.11.2022 | GR | 01.12.2022 | IS | 31.12.2022 | PT | 02.01.2023 | [2024/26] |
Former [2024/14] | AL | 31.08.2022 | |
AT | 31.08.2022 | ||
CZ | 31.08.2022 | ||
DK | 31.08.2022 | ||
EE | 31.08.2022 | ||
ES | 31.08.2022 | ||
FI | 31.08.2022 | ||
HR | 31.08.2022 | ||
LT | 31.08.2022 | ||
LV | 31.08.2022 | ||
MC | 31.08.2022 | ||
NL | 31.08.2022 | ||
PL | 31.08.2022 | ||
RO | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
SI | 31.08.2022 | ||
SK | 31.08.2022 | ||
SM | 31.08.2022 | ||
NO | 30.11.2022 | ||
GR | 01.12.2022 | ||
IS | 31.12.2022 | ||
PT | 02.01.2023 | ||
Former [2023/37] | AL | 31.08.2022 | |
AT | 31.08.2022 | ||
CZ | 31.08.2022 | ||
DK | 31.08.2022 | ||
EE | 31.08.2022 | ||
ES | 31.08.2022 | ||
FI | 31.08.2022 | ||
HR | 31.08.2022 | ||
LT | 31.08.2022 | ||
LV | 31.08.2022 | ||
NL | 31.08.2022 | ||
PL | 31.08.2022 | ||
RO | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
SI | 31.08.2022 | ||
SK | 31.08.2022 | ||
SM | 31.08.2022 | ||
NO | 30.11.2022 | ||
GR | 01.12.2022 | ||
IS | 31.12.2022 | ||
PT | 02.01.2023 | ||
Former [2023/30] | AL | 31.08.2022 | |
AT | 31.08.2022 | ||
CZ | 31.08.2022 | ||
DK | 31.08.2022 | ||
EE | 31.08.2022 | ||
ES | 31.08.2022 | ||
FI | 31.08.2022 | ||
HR | 31.08.2022 | ||
LT | 31.08.2022 | ||
LV | 31.08.2022 | ||
NL | 31.08.2022 | ||
PL | 31.08.2022 | ||
RO | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
SK | 31.08.2022 | ||
SM | 31.08.2022 | ||
NO | 30.11.2022 | ||
GR | 01.12.2022 | ||
IS | 31.12.2022 | ||
PT | 02.01.2023 | ||
Former [2023/29] | AL | 31.08.2022 | |
AT | 31.08.2022 | ||
CZ | 31.08.2022 | ||
DK | 31.08.2022 | ||
EE | 31.08.2022 | ||
ES | 31.08.2022 | ||
FI | 31.08.2022 | ||
HR | 31.08.2022 | ||
LT | 31.08.2022 | ||
LV | 31.08.2022 | ||
PL | 31.08.2022 | ||
RO | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
SK | 31.08.2022 | ||
SM | 31.08.2022 | ||
NO | 30.11.2022 | ||
GR | 01.12.2022 | ||
IS | 31.12.2022 | ||
PT | 02.01.2023 | ||
Former [2023/23] | AT | 31.08.2022 | |
CZ | 31.08.2022 | ||
DK | 31.08.2022 | ||
EE | 31.08.2022 | ||
ES | 31.08.2022 | ||
FI | 31.08.2022 | ||
HR | 31.08.2022 | ||
LT | 31.08.2022 | ||
LV | 31.08.2022 | ||
PL | 31.08.2022 | ||
RO | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
SK | 31.08.2022 | ||
SM | 31.08.2022 | ||
NO | 30.11.2022 | ||
GR | 01.12.2022 | ||
IS | 31.12.2022 | ||
PT | 02.01.2023 | ||
Former [2023/22] | AT | 31.08.2022 | |
CZ | 31.08.2022 | ||
DK | 31.08.2022 | ||
ES | 31.08.2022 | ||
FI | 31.08.2022 | ||
HR | 31.08.2022 | ||
LT | 31.08.2022 | ||
LV | 31.08.2022 | ||
PL | 31.08.2022 | ||
RO | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
SM | 31.08.2022 | ||
NO | 30.11.2022 | ||
GR | 01.12.2022 | ||
IS | 31.12.2022 | ||
PT | 02.01.2023 | ||
Former [2023/21] | DK | 31.08.2022 | |
FI | 31.08.2022 | ||
HR | 31.08.2022 | ||
LT | 31.08.2022 | ||
LV | 31.08.2022 | ||
PL | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
SM | 31.08.2022 | ||
NO | 30.11.2022 | ||
GR | 01.12.2022 | ||
IS | 31.12.2022 | ||
Former [2023/20] | FI | 31.08.2022 | |
HR | 31.08.2022 | ||
LT | 31.08.2022 | ||
LV | 31.08.2022 | ||
PL | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
SM | 31.08.2022 | ||
NO | 30.11.2022 | ||
GR | 01.12.2022 | ||
IS | 31.12.2022 | ||
Former [2023/12] | FI | 31.08.2022 | |
HR | 31.08.2022 | ||
LT | 31.08.2022 | ||
LV | 31.08.2022 | ||
PL | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
NO | 30.11.2022 | ||
GR | 01.12.2022 | ||
IS | 31.12.2022 | ||
Former [2023/11] | FI | 31.08.2022 | |
HR | 31.08.2022 | ||
LT | 31.08.2022 | ||
LV | 31.08.2022 | ||
PL | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
NO | 30.11.2022 | ||
GR | 01.12.2022 | ||
Former [2023/10] | FI | 31.08.2022 | |
HR | 31.08.2022 | ||
LT | 31.08.2022 | ||
LV | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
NO | 30.11.2022 | ||
GR | 01.12.2022 | ||
Former [2023/09] | FI | 31.08.2022 | |
LT | 31.08.2022 | ||
LV | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
NO | 30.11.2022 | ||
Former [2023/08] | FI | 31.08.2022 | |
LT | 31.08.2022 | ||
RS | 31.08.2022 | ||
SE | 31.08.2022 | ||
NO | 30.11.2022 | Documents cited: | Search | [A]WO0166533 (ASTRAZENECA AB [SE], et al) [A] 1-13 * the whole document *; | [A]EP1306094 (SHIONOGI & CO [JP]) [A] 1-13* the whole document *; | [A]WO2012064266 (ALBIREO AB [SE], et al) [A] 1-13 * the whole document *; | [A]WO2016062848 (ELOBIX AB [SE]) [A] 1-13 * the whole document *; | [AP]EP3210977 (CJ HEALTHCARE CORP [KR]) [AP] 1-13 * the whole document * | International search | [Y]US2003153513 (SHIOMI TERUO [JP], et al) [Y] 1-11, 13 * See abstract; and paragraphs [0001], [0002], [0006]. *; | [A]US2004254160 (STARKE INGEMAR [SE], et al) [A] 1-13 * See the entire document. *; | [A]US2006083790 (ANDERBERG EVA-KARIN [SE], et al) [A] 1-13 * See the entire document. *; | [Y]JP2012224590 (KIHATA SHUICHI, et al) [Y] 1-10, 12 * See abstract; and paragraphs [0001]-[0003]. *; | [Y]KR20160047378 (CJ HEALTHCARE CORP [KR]) [Y] 1-13 * See claims 1-11; and paragraphs [0004], [0119], [0120]. *; | [PX]KR101844184B (CJ HEALTHCARE CORP [KR]) [PX] 1-13* See claims 1, 7, 8, 11-13. * |